Well-known drug (AAT) could overcome obstacles to islet transplantation

Researchers from Ben-Gurion University of the Negev (BGU) in Beer-Sheva, Israel have demonstrated that treating diabetic animals with alpha-1-antitrypsin (AAT) following an islet transplantation procedure eliminates the inflammation that causes islet transplants to fail. (PNAS Article #08-07627: "Alpha-1-Antitrypsin Monotherapy Induces Immune Tolerance during Islet Allograft Transplantation in Mice") (http://www.pnas.org/content/105/42/16236)

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news144585627.html">Well-known drug (AAT) could overcome obstacles to islet transplantation</a></p> <p>Researchers from Ben-Gurion University of the Negev (BGU) in Beer-Sheva, Israel have demonstrated that treating diabetic animals with alpha-1-antitrypsin (AAT) following an islet transplantation procedure eliminates the inflammation that causes islet transplants to fail. (PNAS Article #08-07627: "Alpha-1-Antitrypsin Monotherapy Induces Immune Tolerance during Islet Allograft Transplantation in Mice") (<A HREF="http://www.pnas.org/content/105/42/16236">http://www.pnas.org/content/105/42/16236</A>)</p>